GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
688166 Brightgene Bio-Medical Technology Co.,Ltd.
- 29.71
- +0.01+0.03%
Market Closed Jan 24 15:00 CST
12.55BMarket Cap66.76P/E (TTM)
30.07High29.26Low80.02KlotVolume29.68Open29.70Pre Close236.71MTurnover1.89%Turnover Ratio62.03P/E (Static)422.47MShares41.3952wk High5.51P/B12.55BFloat Cap19.5352wk Low35.64Limit Up422.47MShs Float72.02Historical High23.76Limit Down2.73%Amplitude16.89Historical Low0.10Dividend TTM29.58Avg Price40.07KlotAsk0.32%Div YieldTTM100Lot Size36.51KlotBid
Brightgene Bio-Medical Technology Co.,Ltd. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 6.77%976.83M | 11.95%657.69M | 11.54%340.13M | 15.94%1.18B | 18.46%914.88M | 17.41%587.48M | 22.77%304.94M | -3.33%1.02B | 3.19%772.32M | 4.43%500.35M |
| Operating revenue | 6.77%976.83M | 11.95%657.69M | 11.54%340.13M | 15.94%1.18B | 18.46%914.88M | 17.41%587.48M | 22.77%304.94M | -3.33%1.02B | 3.19%772.32M | 4.43%500.35M |
| Total operating cost | 14.11%798.34M | 19.72%554.21M | 16.64%267.34M | 25.15%980.32M | 23.89%699.6M | 20.45%462.93M | 26.32%229.2M | -0.78%783.33M | 4.30%564.69M | 8.62%384.34M |
| Operating cost | 8.26%410.24M | 13.81%294.02M | 16.19%145.69M | 38.56%521.41M | 30.85%378.94M | 35.70%258.34M | 38.61%125.39M | -18.32%376.3M | -8.19%289.61M | -8.71%190.38M |
| Operating tax surcharges | 14.60%5.07M | 9.84%3.15M | 12.95%1.58M | 9.35%5.71M | 33.21%4.42M | 68.82%2.87M | 142.25%1.39M | 23.66%5.22M | 17.70%3.32M | -11.92%1.7M |
| Operating expense | 24.69%56.24M | 39.50%39.64M | -10.54%14.81M | -8.60%64.07M | -25.16%45.1M | -38.65%28.42M | 0.40%16.56M | 63.74%70.09M | 168.00%60.27M | 194.12%46.32M |
| Administration expense | 1.95%84.73M | 7.66%55.78M | 0.93%28.54M | 1.31%116.4M | 7.71%83.11M | 4.45%51.81M | 21.43%28.28M | 11.81%114.89M | 5.33%77.16M | 11.56%49.6M |
| Financial expense | 22.61%29.69M | 4.17%18.86M | 30.84%11.67M | 146.34%24.14M | 613.79%24.21M | 625.93%18.11M | 13.16%8.92M | 70.73%9.8M | -161.77%-4.71M | -34.50%2.49M |
| -Interest expense (Financial expense) | 17.92%39.58M | 15.17%27.57M | 30.15%13.91M | 87.36%44.42M | 214.91%33.57M | 202.32%23.94M | 9.58%10.69M | 144.54%23.71M | 22.10%10.66M | 60.50%7.92M |
| -Interest Income (Financial expense) | 15.49%-8.79M | 5.79%-7.01M | 48.52%-1.54M | -703.62%-17.99M | -707.35%-10.4M | -985.37%-7.45M | -126.80%-2.99M | -146.09%-2.24M | -87.32%-1.29M | -37.59%-686.02K |
| Research and development | 29.65%212.38M | 38.09%142.76M | 33.68%65.05M | 20.08%248.59M | 17.81%163.82M | 10.16%103.39M | 13.85%48.66M | 19.47%207.02M | 16.09%139.05M | 18.29%93.85M |
| Credit Impairment Loss | -5.37%-7.25M | -16.91%-4.42M | -49.71%125.75K | -279.70%-2.47M | -146.30%-6.88M | 18.84%-3.78M | 119.38%250.04K | 113.33%1.37M | 60.32%-2.79M | 31.54%-4.66M |
| Asset Impairment Loss | 35.49%-5.23M | 35.49%-5.23M | ---- | -46.70%-21.49M | -13.46%-8.11M | -13.46%-8.11M | ---- | -55.91%-14.65M | -1,549.30%-7.15M | -2,142.32%-7.15M |
| Other net revenue | ||||||||||
| Fair value change income | 295.29%1.01M | -189.76%-1.56M | -840.99%-2.48M | 84.68%-520.01K | 109.73%255.43K | -50.95%1.74M | 228.34%334.71K | -529.84%-3.39M | -20,533.24%-2.62M | 1,031.75%3.55M |
| Invest income | -16.96%-9.63M | -36.98%-6.58M | -192.83%-4.55M | -472.54%-14.74M | -189.46%-8.24M | -146.38%-4.81M | -144.26%-1.55M | -57.14%3.96M | 305.80%9.21M | 516.90%10.36M |
| -Including: Investment income associates | 4.50%-7.16M | -5.48%-4.9M | -135.05%-3.41M | -52.58%-13.61M | -63.55%-7.5M | -49.21%-4.65M | ---1.45M | 3.46%-8.92M | 29.55%-4.58M | 18.56%-3.11M |
| Asset deal income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 57.00%9.89K | --0 | ---- |
| Other revenue | 94.09%10.97M | 120.71%8.72M | 472.38%4.8M | 45.12%30.27M | -28.85%5.65M | 45.61%3.95M | 54.25%838.63K | 263.52%20.86M | 76.64%7.95M | -36.19%2.71M |
| Operating profit | -14.96%168.35M | -16.86%94.4M | -6.50%70.69M | -21.44%190.24M | -6.72%197.96M | -6.03%113.54M | 15.80%75.61M | -6.50%242.16M | 6.34%212.21M | 1.06%120.83M |
| Add:Non operating Income | -81.97%35.09K | 151.43%28.59K | 358,861.36%6.32K | -81.06%199.02K | -81.93%194.61K | -98.67%11.37K | -99.99%1.76 | 882.79%1.05M | 1,953.19%1.08M | 2,471.72%854.31K |
| Less:Non operating expense | -33.09%309.66K | -57.05%119.57K | --111.08K | 67.50%1.67M | -41.68%462.78K | -37.76%278.41K | ---- | -39.20%999.01K | -49.66%793.53K | -70.67%447.32K |
| Total profit | -14.98%168.08M | -16.75%94.31M | -6.64%70.59M | -22.06%188.77M | -6.97%197.69M | -6.57%113.28M | 15.78%75.61M | -5.92%242.21M | 7.30%212.5M | 2.68%121.24M |
| Less:Income tax cost | 1.77%21.32M | -18.86%12.08M | -8.20%8.78M | -50.14%15.35M | -39.49%20.95M | -13.13%14.89M | 27.50%9.56M | 54.70%30.78M | 26.98%34.62M | 16.22%17.14M |
| Net profit | -16.96%146.76M | -16.43%82.23M | -6.41%61.81M | -17.97%173.42M | -0.64%176.74M | -5.49%98.39M | 14.26%66.04M | -11.00%211.43M | 4.16%177.88M | 0.75%104.11M |
| Net profit from continuing operation | -16.96%146.76M | -16.43%82.23M | -6.41%61.81M | -17.97%173.42M | -0.64%176.74M | -5.49%98.39M | 14.26%66.04M | -11.00%211.43M | 4.16%177.88M | 0.75%104.11M |
| Less:Minority Profit | -103.66%-30.65M | -118.42%-24.14M | 52.17%-2.26M | -3.00%-29.04M | 23.78%-15.05M | -39.96%-11.05M | -59.97%-4.72M | -341.03%-28.2M | -224.17%-19.75M | -123.31%-7.9M |
| Net profit of parent company owners | -7.50%177.41M | -2.81%106.36M | -9.47%64.07M | -15.51%202.47M | -2.95%191.79M | -2.29%109.44M | 16.48%70.77M | -1.77%239.62M | 11.73%197.62M | 4.80%112M |
| Earning per share | ||||||||||
| Basic earning per share | -6.67%0.42 | -3.85%0.25 | -11.76%0.15 | -17.24%0.48 | -6.25%0.45 | -3.70%0.26 | 13.33%0.17 | -3.33%0.58 | 11.63%0.48 | 3.85%0.27 |
| Diluted earning per share | -6.67%0.42 | -3.85%0.25 | -11.76%0.15 | -17.24%0.48 | -6.25%0.45 | -3.70%0.26 | 13.33%0.17 | -3.33%0.58 | 11.63%0.48 | 3.85%0.27 |
| Other composite income | -614.69%-35.07M | -766.40%-35.14M | -2.29M | 22.82%-26.4M | -2,417.43%-4.91M | -548.86%-4.06M | -3,236.33%-34.2M | 270.05%211.75K | 227.26%903.5K | |
| Other composite income of parent company owners | -614.69%-35.07M | -766.40%-35.14M | ---2.29M | 22.82%-26.4M | -2,417.43%-4.91M | -548.86%-4.06M | ---- | -3,236.33%-34.2M | 270.05%211.75K | 227.26%903.5K |
| Total composite income | -35.00%111.69M | -50.08%47.09M | -9.87%59.52M | -17.04%147.02M | -3.51%171.83M | -10.17%94.33M | 14.26%66.04M | -25.07%177.22M | 4.36%178.09M | 2.33%105.01M |
| Total composite income of parent company owners | -23.84%142.34M | -32.41%71.23M | -12.70%61.78M | -14.29%176.07M | -5.54%186.88M | -6.66%105.38M | 16.48%70.77M | -15.44%205.42M | 11.93%197.84M | 6.36%112.9M |
| Total composite income of minority owners | -103.66%-30.65M | -118.42%-24.14M | 52.17%-2.26M | -3.00%-29.04M | 23.78%-15.05M | -39.96%-11.05M | -59.97%-4.72M | -341.03%-28.2M | -224.17%-19.75M | -123.31%-7.9M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.